Paper10073734
The use of atypical antipsychotics in the management of schizophrenia.
Campbell M and 4 others. Br J Clin Pharmacol, 1999. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. The use of atypical antipsychotics in the management of schizophrenia. Papers, record 10073734. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10073734
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Schizophrenia | Major topic |
| Basal Ganglia Diseases | |
| Clinical Trials as Topic | |
| Cost-Benefit Analysis | |
| Humans | |
| Mood Disorders |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7537287 | Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia. | J Clin Psychopharmacol | 1995 | https://conductscience.org/library/papers/7537287 | PubMed |
| 2 | 9337946 | Cost-effectiveness of clozapine. A UK clinic-based study. | Br J Psychiatry | 1997 | https://conductscience.org/library/papers/9337946 | PubMed |
| 3 | 9298518 | Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study Group. | Psychopharmacology (Berl) | 1997 | https://conductscience.org/library/papers/9298518 | PubMed |
| 4 | 7494570 | Schizophrenia. | N Engl J Med | 1996 | https://conductscience.org/library/papers/7494570 | PubMed |
| 5 | 7523815 | Risperidone-induced neuroleptic malignant syndrome. | Lancet | 1994 | https://conductscience.org/library/papers/7523815 | PubMed |
| 6 | 8611817 | Treatment resistance in schizophrenia. | BMJ | 1996 | https://conductscience.org/library/papers/8611817 | PubMed |
| 7 | 2282615 | An update on the epidemiology of schizophrenia. | Can J Psychiatry | 1990 | https://conductscience.org/library/papers/2282615 | PubMed |
| 8 | 8822534 | Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. | Neuropsychopharmacology | 1996 | https://conductscience.org/library/papers/8822534 | PubMed |
| 9 | 9270900 | Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. | Biol Psychiatry | 1997 | https://conductscience.org/library/papers/9270900 | PubMed |
| 10 | 9117479 | Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone. | Psychiatr Serv | 1996 | https://conductscience.org/library/papers/9117479 | PubMed |
| 11 | 8935813 | A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia. | Psychopharmacology (Berl) | 1996 | https://conductscience.org/library/papers/8935813 | PubMed |
| 12 | 8094781 | Schizophrenia: developmental neuroscience and pathobiology. | Lancet | 1993 | https://conductscience.org/library/papers/8094781 | PubMed |
| 13 | 9315992 | Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. | J Clin Psychopharmacol | 1997 | https://conductscience.org/library/papers/9315992 | PubMed |
| 14 | 8425137 | Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. | Br J Psychiatry | 1993 | https://conductscience.org/library/papers/8425137 | PubMed |
| 15 | 8610833 | Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. | Am J Psychiatry | 1996 | https://conductscience.org/library/papers/8610833 | PubMed |
| 16 | 9241010 | Economic and health state utility determinations for schizophrenic patients treated with risperidone or haloperidol. | J Clin Psychopharmacol | 1997 | https://conductscience.org/library/papers/9241010 | PubMed |
| 17 | 8515788 | Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8515788 | PubMed |
| 18 | 10172917 | Measuring quality of life in patients with schizophrenia. | Pharmacoeconomics | 1997 | https://conductscience.org/library/papers/10172917 | PubMed |
| 19 | 9350955 | A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. | Acta Psychiatr Scand | 1997 | https://conductscience.org/library/papers/9350955 | PubMed |
| 20 | 9169300 | Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial. | Eur Neuropsychopharmacol | 1997 | https://conductscience.org/library/papers/9169300 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40161932 | Unlocking the potential of lumateperone and novel anti-psychotics for schizophrenia. | Bioimpacts | 2025 | https://conductscience.org/library/papers/40161932 | PubMed |
| 36895943 | Vitamin D supplementation is effective for olanzapine-induced dyslipidemia. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36895943 | PubMed |
| 34491479 | Involvement of anti-inflammatory, antioxidant, and BDNF up-regulating properties in the antipsychotic-like effect of the essential oil of Alpinia zerumbet in mice: a comparative study with olanzapine. | Metab Brain Dis | 2021 | https://conductscience.org/library/papers/34491479 | PubMed |
| 33580033 | One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia. | NPJ Schizophr | 2021 | https://conductscience.org/library/papers/33580033 | PubMed |
| 28701621 | Antipsychotic-like activity of scopoletin and rutin against the positive symptoms of schizophrenia in mouse models. | Exp Anim | 2017 | https://conductscience.org/library/papers/28701621 | PubMed |
| 28088913 | A Comparative Study of Short Term Efficacy of Aripiprazole and Risperidone in Schizophrenia. | Curr Neuropharmacol | 2017 | https://conductscience.org/library/papers/28088913 | PubMed |
| 26599405 | Asenapine versus placebo for schizophrenia. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/26599405 | PubMed |
| 22558126 | Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics. | PLoS One | 2012 | https://conductscience.org/library/papers/22558126 | PubMed |
| 17876506 | Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia. | Eur Child Adolesc Psychiatry | 2008 | https://conductscience.org/library/papers/17876506 | PubMed |
| 15649104 | Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death. | Drug Saf | 2005 | https://conductscience.org/library/papers/15649104 | PubMed |
| 14728058 | Long-acting risperidone: a review of its use in schizophrenia. | CNS Drugs | 2004 | https://conductscience.org/library/papers/14728058 | PubMed |
| 14720078 | Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs. | Pharmacoeconomics | 2004 | https://conductscience.org/library/papers/14720078 | PubMed |
| 12383035 | Aripiprazole. | CNS Drugs | 2002 | https://conductscience.org/library/papers/12383035 | PubMed |
| 10843459 | Biotransformation of post-clozapine antipsychotics: pharmacological implications. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10843459 | PubMed |
| 10740987 | Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics. | J Psychiatry Neurosci | 2000 | https://conductscience.org/library/papers/10740987 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10073734
GET https://conductscience.org/api/papers/v1/10073734/references?page=2